Partners
At Indica Labs, we’ve built an ecosystem of partnerships to promote open pathology and interoperability, enabling our customers to choose best-of-breed products across integrated digital pathology workflows.
ACD, a Bio-Techne brand
ACD, a Bio-Techne brand, with proprietary RNAscope™ Technology, the first multiplex fluorescent and chromogenic ISH platform, enables multiomic RNA and Protein detection within spatial context.
Our portfolio includes RNAscope, BaseScope™, miRNAscope™, RNAscope Plus, Multiplex Fluorescent V2 and HiPlex™ v2. With 49,000+ unique probes, 9,900+ articles, and our Professional Assay Services, we enable rapid visualization of unique targets.
Lunaphore, a Bio-Techne brand
Lunaphore – a Bio-Techne brand, was born with the vision of enabling spatial biology in every laboratory. Lunaphore empowers researchers to push the boundaries of scientific discovery and drug development. Its flagship COMET™ platform is a fully automated, high-throughput, hyperplex platform offering scalability and reproducibility without the need for conjugation.
Akoya Biosciences
Our mission is to bring context to the world of biology and human health through the power of spatial phenotyping. We offer comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy.
Dell
Dell Technologies provides solutions to help healthcare and life sciences organizations manage the data growth associated with digital pathology by providing scalable, performant, and secure IT infrastructure. Our solutions power computational pathology and AI applications while simplifying the management of whole slide imaging data from within the data center and to the cloud.
Lunit
Lunit develops AI-powered medical image analysis software via cutting-edge deep learning technology. Our systems can help physicians make accurate and efficient clinical decisions through data-driven imaging biomarkers, improving cancer therapy outcomes.
Merge by Merative
Merge medical imaging solutions, offered by Merative, combine intelligent, scalable imaging workflow tools with deep and broad expertise to help healthcare organizations improve their confidence in patient outcomes and optimize care delivery.
Xyall
Xyall is active in the field of oncology based molecular diagnostic testing. Xyall is on a mission to optimize molecular diagnostic test results for cancer patients with their fully automated Tissector solutions that enable accurate and efficient selection of tumor samples.
DeepBio
Deep Bio is an AI healthcare company focusing on deep learning to advance the field of cancer pathology. Its flagship product, DeepDx® Prostate, is an AI-powered software for the assessment of prostate cancer on digital whole slide images, providing Gleason grading, percent tumor involvement, and tumor-to-tissue measurements.
IBEX
Ibex Medical Analytics is transforming cancer diagnostics with world-leading clinical grade AI-powered solutions for pathology. Pathologists worldwide use Galen™ as part of their everyday routine to improve the accuracy of cancer diagnosis, implement comprehensive quality control measures, reduce turnaround times and boost productivity with more efficient workflows.
Hamamatsu
Hamamatsu Photonics K.K. is a global leader in the design and manufacturing of photonics devices, including advanced imaging detectors for medical, environmental, biological, and semi-conductor industries. Building on over 60 years of engineering experience, our NanoZoomer line of digital scanners has been a trailblazer in whole slide imaging scanner technology for pathology research and clinical diagnostics with 510(k) cleared NanoZoomer S360 MD system. Renowned for excellent image quality, reliability, and interoperability, the NanoZoomer line has been at the forefront of digital pathology for over two decades.
Molecular Instruments
Molecular Instruments synthesizes kits powered by its innovative HCR™ platform for bioimaging applications in academic research, drug development, and clinical pathology and diagnostics. We offer products for automated and manual chromogenic and fluorescence in situ hybridization (ISH) assays, featuring a protease-free workflow and native compatibility with existing IHC/IF assays that facilitates straightforward image analysis.
Histofy
Histofy is dedicated to developing transparent AI solutions for computational pathology, with a special focus on deep tissue profiling to improve patient outcomes. The company’s innovative technology is aimed at precision histology and its integration with existing workflows to streamline pathology and deliver personalized medicine.
Paige
Paige is pioneering AI-driven cancer solutions, revolutionizing detection, diagnosis, and treatment with cutting-edge technology. As the first FDA-approved AI in pathology, Paige combines a deep understanding of cancer with next-generation applications, setting new benchmarks in precision diagnostics and turning insights into transformative, life-saving innovations.
ACD, a Bio-Techne brand
ACD, a Bio-Techne brand, with proprietary RNAscope™ Technology, the first multiplex fluorescent and chromogenic ISH platform, enables multiomic RNA and Protein detection within spatial context.
Our portfolio includes RNAscope, BaseScope™, miRNAscope™, RNAscope Plus, Multiplex Fluorescent V2 and HiPlex™ v2. With 49,000+ unique probes, 9,900+ articles, and our Professional Assay Services, we enable rapid visualization of unique targets.
Lunaphore, a Bio-Techne brand
Lunaphore – a Bio-Techne brand, was born with the vision of enabling spatial biology in every laboratory. Lunaphore empowers researchers to push the boundaries of scientific discovery and drug development. Its flagship COMET™ platform is a fully automated, high-throughput, hyperplex platform offering scalability and reproducibility without the need for conjugation.
Akoya Biosciences
Our mission is to bring context to the world of biology and human health through the power of spatial phenotyping. We offer comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy.
Dell
Dell Technologies provides solutions to help healthcare and life sciences organizations manage the data growth associated with digital pathology by providing scalable, performant, and secure IT infrastructure. Our solutions power computational pathology and AI applications while simplifying the management of whole slide imaging data from within the data center and to the cloud.
Molecular Instruments
Molecular Instruments synthesizes kits powered by its innovative HCR™ platform for bioimaging applications in academic research, drug development, and clinical pathology and diagnostics. We offer products for automated and manual chromogenic and fluorescence in situ hybridization (ISH) assays, featuring a protease-free workflow and native compatibility with existing IHC/IF assays that facilitates straightforward image analysis.
Paige
Paige is pioneering AI-driven cancer solutions, revolutionizing detection, diagnosis, and treatment with cutting-edge technology. As the first FDA-approved AI in pathology, Paige combines a deep understanding of cancer with next-generation applications, setting new benchmarks in precision diagnostics and turning insights into transformative, life-saving innovations.
Lunit
Lunit develops AI-powered medical image analysis software via cutting-edge deep learning technology. Our systems can help physicians make accurate and efficient clinical decisions through data-driven imaging biomarkers, improving cancer therapy outcomes.
Xyall
Xyall is active in the field of oncology based molecular diagnostic testing. Xyall is on a mission to optimize molecular diagnostic test results for cancer patients with their fully automated Tissector solutions that enable accurate and efficient selection of tumor samples.
DeepBio
Deep Bio is an AI healthcare company focusing on deep learning to advance the field of cancer pathology. Its flagship product, DeepDx® Prostate, is an AI-powered software for the assessment of prostate cancer on digital whole slide images, providing Gleason grading, percent tumor involvement, and tumor-to-tissue measurements.
Merge by Merative
Merge medical imaging solutions, offered by Merative, combine intelligent, scalable imaging workflow tools with deep and broad expertise to help healthcare organizations improve their confidence in patient outcomes and optimize care delivery.
IBEX
Ibex Medical Analytics is transforming cancer diagnostics with world-leading clinical grade AI-powered solutions for pathology. Pathologists worldwide use Galen™ as part of their everyday routine to improve the accuracy of cancer diagnosis, implement comprehensive quality control measures, reduce turnaround times and boost productivity with more efficient workflows.
Hamamatsu
Hamamatsu Photonics K.K. is a global leader in the design and manufacturing of photonics devices, including advanced imaging detectors for medical, environmental, biological, and semi-conductor industries. Building on over 60 years of engineering experience, our NanoZoomer line of digital scanners has been a trailblazer in whole slide imaging scanner technology for pathology research and clinical diagnostics with 510(k) cleared NanoZoomer S360 MD system. Renowned for excellent image quality, reliability, and interoperability, the NanoZoomer line has been at the forefront of digital pathology for over two decades.
Histofy
Histofy is dedicated to developing transparent AI solutions for computational pathology, with a special focus on deep tissue profiling to improve patient outcomes. The company’s innovative technology is aimed at precision histology and its integration with existing workflows to streamline pathology and deliver personalized medicine.
Paige
Paige is pioneering AI-driven cancer solutions, revolutionizing detection, diagnosis, and treatment with cutting-edge technology. As the first FDA-approved AI in pathology, Paige combines a deep understanding of cancer with next-generation applications, setting new benchmarks in precision diagnostics and turning insights into transformative, life-saving innovations.